Listar por autor "Grande, Enrique"
Mostrando ítems 1-5 de 5
-
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. Strosberg, Jonathan; El-Haddad, Ghassan; Wolin, Edward; Grande, Enrique; Krenning, Eric (The New England Journal of Medicine, 2017)
-
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. Kulke, Matthew H.; Hörsch, Dieter; Caplin, Martyn E.; Grande, Enrique; Pavel, Marianne (Journal of Clinical Oncology, 2016)
-
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407). Grande, Enrique; Teulé, Alex; Alonso‐Gordoa, Teresa; Jiménez Fonseca, Paula; Benavent, Marta; Capdevila, Jaume; Custodio, Ana; Vera, Ruth; García‐Carbonero, Rocío (The Oncologist, 2020)